Hindustan Unilever Ltd (HUL) is expected to report subdued Q3 earnings for December 2024 due to weak urban demand, despite gradual rural recovery. Revenues are projected to grow by 2% YoY with a 3% rise in PAT. Analysts anticipate a 1% underlying volume growth, affected by price hikes in soaps and tea.
FMCG giant Hindustan Unilever (HUL) is projected to post a 2-4% rise in Q2FY25 revenue, partially impacted by pricing cuts made during the quarter. The revenue is estimated to range between Rs 15,621 crore and Rs 15,728 crore, as per estimates from four brokerages.
The USA prenatal nutrition industry is projected to grow at a 5.6% CAGR, driven by innovations in nutritional formulations, including probiotics, omega-3s,...
A Key Growth Driver for the Global OTC Consumer Healthcare Market is the Increasing Consumer Preference for Convenient, Self-Medication Solutions for...
Investment activity in July focused on BDCs with $2,000 added to the market. Adjusted dividend income in July of $709, up 19% Y/Y and down 4% sequentially. Read more here.
Investment activity remained high in June, focusing on BDCs aiming to increase dividend income by at least $100 each month. Click here for my portfolio picks.